Tag: #prostatecancer

Articles related to prostatecancer

health

FDA Expands Approval of Talzenna Plus Xtandi for HRR‑Mutated Metastatic Castration‑Sensitive Prostate Cancer

FDA on Oct. 26 approved Talzenna plus Xtandi for HRR‑mutated metastatic castration‑sensitive prostate cancer; genetic testing required.

$PFE, #fda, #prostatecancer, #oncology, #pfizer

health

Radioligand 177Lu-PSMA-617 Delays Radiographic Progression in PSMA-Positive Hormone-Sensitive Metastatic Prostate Cancer, Phase 3 Trial Shows

Phase 3 PSMAddition trial found 177Lu‑PSMA‑617 added to hormonal therapy reduced risk of radiographic progression in PSMA‑positive mHSPC.

#prostatecancer, #radioligandtherapy, #pluvicto, #clinicaltrials